Literature DB >> 1315279

Pitfalls in scintigraphic detection of neuroendocrine tumours.

L Feggi1, E Degli Uberti, G C Pansini, G Transforini, N Prandini, M R Ambrosio, A R D'Urso, R Faggioli.   

Abstract

We report 4 cases of abnormal results using iodine-123 metaiodobenzylguanidine (123I-mIBG) or technetium-99m (V) dimercaptosuccinic acid (99mTc(V)-DMSA) scintigraphy in the diagnosis and follow-up of presumed neuroendocrine tumours. The present series consisted of 2 false-positive cases (1 adenomatous polyp of the caecum with mIBG and 1 follicular adenoma of the thyroid with DMSA) and 2 cases of anomalous uptake of (V)-DMSA in a non-neuroendocrine tissue.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1315279     DOI： 10.1007/bf00173284

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  11 in total

1.  Radioiodinated metaiodobenzylguanidine (*I-MIBG) scintigraphy in neuroblastoma: a review of 160 studies.

Authors:  L Troncone; V Rufini; F M Danza; A Donfrancesco; C De Laurentis; R Cozza; R Riccardi; A Lasorella; R Mastrangelo
Journal:  J Nucl Med Allied Sci       Date:  1990 Oct-Dec

2.  Imaging of medullary thyroid cancer with 131I-MIBG.

Authors:  K Endo; K Shiomi; K Kasagi; J Konishi; K Torizuka; K Nakao; H Tanimura
Journal:  Lancet       Date:  1984-07-28       Impact factor: 79.321

3.  Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.

Authors:  L Von Moll; A J McEwan; B Shapiro; J C Sisson; M D Gross; R Lloyd; E Beals; W H Beierwaltes; N W Thompson
Journal:  J Nucl Med       Date:  1987-06       Impact factor: 10.057

4.  Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.

Authors:  T E Hilditch; J M Connell; A T Elliot; T Murray; N S Reed
Journal:  J Nucl Med       Date:  1986-07       Impact factor: 10.057

5.  Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine.

Authors:  C A Hoefnagel; P A Voûte; J de Kraker; H R Marcuse
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

6.  Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.

Authors:  D A Wulfrank; K H Schelstraete; F Small; C J Fallais
Journal:  Clin Nucl Med       Date:  1989-08       Impact factor: 7.794

7.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

8.  A new imaging agent for medullary carcinoma of the thyroid.

Authors:  H Ohta; K Yamamoto; K Endo; T Mori; D Hamanaka; A Shimazu; K Ikekubo; K Makimoto; Y Iida; J Konishi
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

9.  Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.

Authors:  H Ohta; K Endo; T Fujita; J Konishi; K Torizuka; K Horiuchi; A Yokoyama
Journal:  Nucl Med Commun       Date:  1988-02       Impact factor: 1.690

10.  Scintigraphic localization of pheochromocytoma.

Authors:  J C Sisson; M S Frager; T W Valk; M D Gross; D P Swanson; D M Wieland; M C Tobes; W H Beierwaltes; N W Thompson
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245
View more
  5 in total

1.  131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Francesco Giammarile; Cumali Aktolun; Richard P Baum; Angelika Bischof Delaloye; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Giovanna Pepe; Sven N Reske; Maria R Castellani; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12       Impact factor: 9.236

2.  Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma.

Authors:  Punit Sharma; Varun Singh Dhull; Saurabh Arora; Poonam Gupta; Rajeev Kumar; Prashant Durgapal; Arun Malhotra; Sunil Chumber; Ariachery C Ammini; Rakesh Kumar; Chandrasekhar Bal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-25       Impact factor: 9.236

3.  Elevated 131I-MIBG activity in adrenocortical adenoma-what other imaging options do we have?

Authors:  Xiaotian Xia; Keshan Wang; Fuqiang Shao; Fan Hu; Shengqing Hu; Yu Dai; Yongxue Zhang; Xiaoli Lan
Journal:  Quant Imaging Med Surg       Date:  2022-04

4.  False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.

Authors:  C Letizia; G De Toma; R Massa; A Corsi; C Caliumi; S Subioli; E D'Erasmo
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

5.  Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.

Authors:  N L Hadj-Djilani; N E Lebtahi; A B Delaloye; R Laurini; D Beck
Journal:  Eur J Nucl Med       Date:  1995-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.